Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company also provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. Its technology includes diagnostic and therapeutic. It has developed a novel diagnostic assay for the early and rapid diagnosis of sepsis, based on the detection of molecular signatures of sepsis specific to the immune response, rather than the presence of a pathogen.


CSE:ASEP - Post by User

Asep Medical Holdings Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(83)
•••
Post by biggonadson Feb 16, 2022 1:18pm
126 Views
Post# 34434457

This now means ASEP's grants total over $20M

This now means ASEP's grants total over $20MASEP Medical announces it’ll be working with iFyber and the US Army for pre-clinical development of its antibiofilm peptides.Collaborating with iFyber to develop wound dressings incorporating ASEP’s novel peptide technologies  An exciting time for ASEP as its efforts are supported by huge players including the US army, National Institute of Health, Canadian Institute of Health Research, the Bill and Melinda Gates foundation, Genome Canada and more - these financial backers have provided grants totalling over $20M for both peptide therapy and its core Sepsis diagnostics. See the full announcement online  https://www.prnewswire.com/news-releases/asep-medical-inc-announces-its-antibiofilmanti-inflammatory-peptide-technology-is-in-advanced-development-for-wound-dressings-with-us-army-funding1-301483229.html
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities